NEMOLIZUMAB Pharmacologic Class Indexing

Class set ID
cd69a867-1610-4c2e-a2da-69fb36cfc834
Version
1
Effective date
20250205
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use NEMLUVIO safely and effectively. See full prescribing information for NEMLUVIO. NEMLUVIO ® (nemolizumab-ilto) for injection, for subcutaneous use Initial U.S. Approval: 2024Galderma Laboratories, L.P. | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) | SHL Medical Assembly & Services LLC202506265